| Dr John Alvin Stewart, MD | |
|
122 N 20th St, Bldg 25, Opelika, AL 36801-5442 | |
| (334) 749-5604 | |
| (334) 749-3040 |
| Full Name | Dr John Alvin Stewart |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 48 Years |
| Location | 122 N 20th St, Opelika, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265423313 | NPI | - | NPPES |
| 510-06042 | Other | AL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 00009216 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| East Alabama Medical Center And Snf | Opelika, AL | Hospital |
| Entity Name | John A. Stewart M.d., P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508162231 PECOS PAC ID: 3971774951 Enrollment ID: O20110923000083 |
News Archive
TeamHealth Holdings Inc., a leading physician services organization, announced the acquisition of the operations of three affiliated medical groups: Fremont Emergency Services, Advanced Care Emergency Services and Advanced Care Emergency Specialists, which collectively manage and staff eight hospital emergency departments in the Las Vegas, Nevada, market.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that the US Military Malaria Vaccine Program presented results of its study using the Biojector2000 with a recombinant DNA vaccine at two recent conferences. A Cooperative Research and Development Agreement was signed with the Navy in April 2009 to work together on the study.
A study conducted by Children's Hospital & Research Center Oakland scientists identifies a new class of therapeutic agents found naturally in soy that can prevent and possibly treat colon cancer, the third most deadly form of cancer. Sphingadienes (SDs) are natural lipid molecules found in soy that research shows may be the key to fighting colon cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Alvin Stewart, MD 122 N 20th St, Bldg 25, Opelika, AL 36801-5442 Ph: (334) 749-5604 | Dr John Alvin Stewart, MD 122 N 20th St, Bldg 25, Opelika, AL 36801-5442 Ph: (334) 749-5604 |
News Archive
TeamHealth Holdings Inc., a leading physician services organization, announced the acquisition of the operations of three affiliated medical groups: Fremont Emergency Services, Advanced Care Emergency Services and Advanced Care Emergency Specialists, which collectively manage and staff eight hospital emergency departments in the Las Vegas, Nevada, market.
Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that since the 2008 retrospective analysis of patient-level claims data, Boehringer Ingelheim/Pfizer's Spiriva has closed the gap in patient share between itself and GlaxoSmithKline's Advair in newly diagnosed chronic obstructive pulmonary disease (COPD) patients. Although Advair's patient share in the first line is still greater than Spiriva's, Spiriva has surpassed Advair in the second line and will continue to overcome and widen the gap between itself and Advair over the next two years.
Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that the US Military Malaria Vaccine Program presented results of its study using the Biojector2000 with a recombinant DNA vaccine at two recent conferences. A Cooperative Research and Development Agreement was signed with the Navy in April 2009 to work together on the study.
A study conducted by Children's Hospital & Research Center Oakland scientists identifies a new class of therapeutic agents found naturally in soy that can prevent and possibly treat colon cancer, the third most deadly form of cancer. Sphingadienes (SDs) are natural lipid molecules found in soy that research shows may be the key to fighting colon cancer.
› Verified 6 days ago